The success of Sildenafil initially drove a surge for major pharmaceutical companies, nevertheless recent changes present a uncertain scenario for investors. Lower-cost versions are eroding earnings, and persistent https://neiloohf561166.slypage.com/41741169/viagra-and-pharma-a-risky-investment